.
Department of Tuberculosis, Wuhan Jinyintan Hospital, Wuhan, Hubei 430023, China..
Cell Mol Biol (Noisy-le-grand). 2022 Feb 28;68(2):60-63. doi: 10.14715/cmb/2022.68.2.9.
This experiment was conducted to investigate the effect of taking Baihe Gujin decoction combined with Shengmai powder on IL-1β and IL-1Ra expression in peripheral blood CD14+ monocytes from patients with pulmonary tuberculosis. For this purpose, one hundred adult patients with primary pulmonary tuberculosis were selected for the study. The age of the enrolled cases ranged from 18 to 60 years old, with a controlled male to the female sex ratio of about 1:1. The Chinese medical evidence was considered to be a qi-yin deficiency type of pulmonary consumption. The patients were randomly divided into experimental and control groups, 50 cases each. In addition, 50 cases of healthy people were selected as a healthy control group, totaling 150 cases. In the experimental group, patients were given Baihe gujin decoction and Shengmai powder based on conventional western medicine, 1 dose for 1 day, 150mL/time for 2 times. The control group was treated with conventional Western medicine. 2 mL of fasting elbow venous blood from the subjects was taken in the morning. Peripheral blood mononuclear cells were isolated by density centrifugation. Monocytes were obtained after incubation with 5 μL of CD14+ immune magnetic beads at 4°C. The relative expression of IL1β and IL1R genes were measured using real-time quantitative PCR (RT-PCR), respectively. Results showed that the relative expression of IL1β and IL1R genes was significantly lower in the experimental group after 3 months compared with the control group, and the statistical difference was highly significant (p<0.01). It was concluded that the administration of Baihe gujin decoction and Shengmai powder was closely related to the relative expression of IL1β and IL1R genes in patients' serum, indicating that Baihe gujin decoction and Shengmai powder have an important role in improving the clinical symptoms of pulmonary tuberculosis.
这项实验旨在研究服用百合固金汤合生脉散对肺结核患者外周血 CD14+单核细胞中 IL-1β和 IL-1Ra 表达的影响。为此,选择了 100 例成人原发性肺结核患者进行研究。纳入病例的年龄在 18 至 60 岁之间,男女比例约为 1:1。中医证据被认为是气阴两虚型肺痨。患者被随机分为实验组和对照组,每组 50 例。此外,选择了 50 例健康人作为健康对照组,共计 150 例。实验组患者在常规西药的基础上加用百合固金汤合生脉散,1 天 1 剂,150mL/次,2 次/d。对照组给予常规西药治疗。采集受试者清晨空腹肘静脉血 2 mL,采用密度梯度离心法分离外周血单个核细胞,孵育 4°C 下用 5 μL CD14+免疫磁珠获得单核细胞。采用实时定量 PCR(RT-PCR)分别检测 IL1β和 IL1R 基因的相对表达量。结果显示,治疗 3 个月后实验组患者 IL1β 和 IL1R 基因的相对表达量明显低于对照组,差异有统计学意义(p<0.01)。结论:百合固金汤合生脉散的应用与患者血清中 IL1β 和 IL1R 基因的相对表达密切相关,表明百合固金汤合生脉散在改善肺结核临床症状方面具有重要作用。